Use of sirolimus for Epstein-Barr virus-positive smooth-muscle tumour.
Toh
Han Chong
HC
Department of Medical Oncology, National Cancer Centre, Singapore.
Teo
Marissa
M
Ong
Kong Wee
KW
Lee
Victor
V
Chan
Errol
E
Lee
Ann S G
AS
Vathsala
Anantharaman
A
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy* / Q000821:virology; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D004854:Herpesvirus 4, Human; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000821:virology; D008875:Middle Aged; D020123:Sirolimus / Q000627:therapeutic use*; D018235:Smooth Muscle Tumor / Q000188:drug therapy* / Q000821:virology
D000903:Antibiotics, Antineoplastic; D007166:Immunosuppressive Agents; D020123:Sirolimus